Omnix Medical Wins €10.8M in EIC Accelerator Funding

OmnixMedical, a Jerusalem-based biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, has been awarded €10.8 million in EU funding under the EIC Accelerator Programme. The award will…

Continue Reading Omnix Medical Wins €10.8M in EIC Accelerator Funding